About Spineart
Spineart is a Healthcare company based in Plan-les-ouates (Switzerland) founded in 2005 by Stephane Mugnier-Jacob. It operates as a developer of orthopedic implants and minimally invasive instruments. Spineart has raised $116.77 million across 4 funding rounds from investors including Gimv and Ernst Göhner Stiftung. Spineart has completed 1 acquisition, including Meditech Spine. Spineart offers products and services including BAGUERA® C and PERLA® App. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is SPINEART SA. Its competitors include GE Healthcare, Medtronic, Boston Scientific, Nevro and CONMED and 5 more; 4 of its 10 listed competitors have raised funding.
Company details
Spineart was founded in 2005 as a developer of medical devices in the orthopedic sector. A range of implants, including cervical cages, fixation systems, posterior and lateral titanium cages, and interspinal fusion devices, is offered for spinal and other orthopedic procedures. Instruments support arthroplasty, cervical fixation, deformity correction, interbody fusion, and thoracolumbar fixation. Certain products have obtained FDA clearance.
- Headquarters Plan-les-ouates, Switzerland
- Founders Stephane Mugnier-Jacob
- SectorsHealthcare
- Website spineart.com
- Social LinkedIn
- Legal Name Spineart Sa
- Total Equity Funding$116.77M (USD)
in 4 rounds
- Latest Funding Round$31.3M (USD), Series B
Sep 2025
- InvestorsGimv
& 1 more
- Investments & Acquisitions
Products & Services of Spineart
Spineart offers a comprehensive portfolio of products and services, including BAGUERA® C and PERLA® App.
Device for treating symptomatic cervical spine disease with motion preservation.
Application for enhancing precision in spine surgery procedures.
Funding Insights of Spineart
Spineart has successfully raised a total of $116.77M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $31.3 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $116.77M
- Total Rounds 4
- Last Round Series B — $31.3M
- First Round $33.5M
(Sep 2016)
- Investors Count 2
All 4 funding rounds of Spineart with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2025 | $31.3M | Series B | – | – | |
| Mar 2024 | $22.51M | Debt – Convertible | – | – | – |
| Jun 2020 | $51.97M | Series B | – | Ernst Göhner | |
| Sep 2016 | $33.5M | Series A | – | Gimv | – |
2 investors in total: 2 institutional.
Investors in Spineart
Spineart has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Gimv and Ernst Göhner Stiftung.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm | 1980 | gimv.com | Antwerp, Belgium | |
A foundation is operated to support cultural and social initiatives. | – | ernst-goehner-stiftung.ch | Zurich, Switzerland |
Investor details for Spineart
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Spineart
102 people are tracked at Spineart (35 in leadership, 7 in board & advisors, 60 in team).
| Name | Role | Group |
|---|---|---|
Stephane Mugnier-Jacob | Co-Founder | Leadership |
Alessia Erlingher | Chief Commercial Officer | Leadership |
Harold Hawkins | Vice President Education | Leadership |
Brett Seibert | Area Sales Director | Leadership |
Patrick Forde | Area Vice President | Leadership |
Franck Pennesi | Chief Technical Officer | Leadership |
Jerome Trividic | CEO | Leadership |
Guillaume Amblard | Chief Product Officer | Leadership |
Scott Ellwanger | Area Sales Director | Leadership |
Bassem Khoury | General Manager | Leadership |
Aaron R. Jennings | Area Sales Director | Leadership |
Mark Medina | Area Sales Director | Leadership |
Olivier Guillaumel | Area VP Sales France And Belux | Leadership |
Edouard Goetgheluck | Senior Vice President Of Sales OUS (europe, Middle East Africa, Latin America, Asia Pacific) | Leadership |
Channy Em | Director Of Communications | Leadership |
Chris Warren | Vice President Research And Development | Leadership |
Dervilla Bermingham | VP Clinical And Scientific Affairs At Spineart | Leadership |
Romain Domange | VP Global Quality Product At Spineart | Leadership |
Etienne Sigaux Vionnet | Industrialization Director | Leadership |
Shane Aiken | Sales Director Uk&i | Leadership |
82 more people are available in the full profile.
Complete people profiles for Spineart
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spineart
Spineart has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Meditech Spine.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Spinal implants are designed and developed by Meditech Spine. | meditechspine.com | Atlanta, United States | 2003 | Jul 2020 | •••• |
Complete acquisition details for Spineart
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Spineart
4 dated milestones of Spineart across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Spineart is founded.
- Funding First funding round of $33.5M.
- Acquisition Acquires Meditech Spine.
- Funding Latest funding round, Series B, of $31.3M.
Competitors of Spineart
Spineart has 10 listed competitors in our database, 4 of them funded. They include GE Healthcare, Medtronic, Boston Scientific, Nevro and CONMED, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gehealthcare.com | 1892 | Chicago, United States | $29.13M | 16,700 | Materials management solutions are provided for healthcare organizations. | |
| medtronic.com | 1949 | Minneapolis, United States | – | 1,114 | Medical equipment for treating over 30 chronic diseases is developed. | |
| bostonscientific.com | 1979 | Marlborough, United States | – | 63,359 | Wide range of medical devices | |
| nevro.com | 2006 | Menlo Park, United States | $154.1M | 1,215 | Provider of high-frequency spinal cord stimulation implants | |
| conmed.com | 1987 | Utica, United States | – | 4,100 | Surgical instruments are manufactured for multiple therapeutic areas. | |
| jnj.com | 1886 | New Brunswick, United States | – | 214 | Healthcare solutions are provided by Johnson & Johnson globally. | |
| atecspine.com | 1990 | San Diego, United States | – | 839 | Treatment solutions for spine disorders are developed. | |
| commure.com | 2016 | San Francisco, United States | $753.3M | 316 | Complex healthcare challenges are addressed through technology solutions by Commure. | |
| hologic.com | 1985 | Marlborough, United States | – | 6,705 | Diagnostic and surgical products for women's healthcare are provided. | |
| vertosmed.com | 2005 | Aliso Viejo, United States | $177.75M | 140 | Minimally invasive treatments for lumbar spinal stenosis are developed. |
Detailed competitors of Spineart
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Spineart
The website of Spineart (spineart.com) receives about 7.2K visits a month.
- Monthly visits7.2K
▼ 3.4% vs previous month
Websites whose visitors overlap most with Spineart. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
dispositivimedici.biz | dispositivimedici.biz | 100% | – | #5,825,756 | – |
| paradigmspine.com | 88% | 1.4K | #11,102,820 | View details | |
alphatecspine.com | alphatecspine.com | 88% | – | #3,976,987 | – |
| endius.com | 55% | – | – | View details | |
| spine-health.com | 55% | – | #94,048 | View details |
Top companies in Orthopedics
10 companies that operate in the same segment as Spineart (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | 4,125 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608.25 M | – | 197 | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Spineart
Complete news archive for Spineart
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spineart
Spineart was founded in 2005 and raised its 1st funding round 11 years after it was founded.
Spineart is headquartered in Plan-les-ouates, Switzerland. It is registered at Plan-les-ouates, Geneva, Switzerland.
Spineart is a funded company, having raised a total of $116.77M across 4 funding rounds to date. The company's 1st funding round was a Series A of $33.5M, raised on Sep 2016.
Spineart was founded in 2005 as a developer of medical devices in the orthopedic sector. A range of implants, including cervical cages, fixation systems, posterior and lateral titanium cages, and interspinal fusion devices, is offered for spinal and other orthopedic procedures. Instruments support arthroplasty, cervical fixation, deformity correction, interbody fusion, and thoracolumbar fixation. Certain products have obtained FDA clearance.
Spineart's top competitors include GE Healthcare, Medtronic and Boston Scientific.
Spineart offers BAGUERA® C and PERLA® App.
Spineart has made 1 acquisition, including Meditech Spine.
Spineart has 2 investors. Key investors include Gimv, and Ernst Göhner Stiftung.
Spineart operates through Spineart Sa.